Among them, the promoter methylation level of CLGN was stronger in the tumor group, while the methylation levels of the other three genes were significantly reduced in the tumor group, especially PPP1R16A (Fig. 8H-M). The gene discussed is PPP1R16A; the disease is neoplasm.